respiratori
diseas
pig
common
modern
pork
product
worldwid
often
refer
porcin
respiratori
diseas
complex
prdc
prdc
polymicrobi
natur
occur
follow
infect
variou
combin
primari
secondari
respiratori
pathogen
varieti
viral
bacteri
pathogen
commonli
associ
prdc
includ
porcin
reproduct
respiratori
syndrom
viru
prrsv
actinobacillu
pleuropneumonia
app
consid
pathogen
major
import
relev
pig
industri
furthermor
bacterialvir
coinfect
exacerb
pathogen
respiratori
pig
diseas
exampl
coinfect
mycoplasma
hyopneumonia
swine
influenza
viru
siv
exhibit
sever
clinic
diseas
prrsv
streptococcu
sui
coinfect
experi
confirm
prrsv
predispos
pig
sui
infect
bacteremia
increas
virul
prrsv
pig
hyopneumonia
infect
increas
effect
prrsv
infect
lesion
prrsv
infect
abl
acceler
haemophilu
parasui
infect
load
studi
coinfect
princip
look
macroscop
lesion
clinic
sign
recent
studi
investig
close
direct
interact
mechan
involv
pathogen
exampl
qiao
collabor
show
prrsv
bacteri
endotoxin
lp
act
synergi
amplifi
inflammatori
respons
infect
macrophag
thu
crucial
develop
new
vitro
model
investig
detail
mechanist
interact
involv
polymicrobi
infect
porcin
reproduct
respiratori
syndrom
prr
econom
devast
viral
diseas
affect
swine
industri
worldwid
etiolog
agent
prrsv
possess
rna
viral
genom
ten
open
read
frame
prrsv
virul
multigen
resid
nonstructur
structur
viral
protein
molecular
characterist
biolog
immunolog
function
prrsv
structur
nonstructur
protein
involv
viru
pathogenesi
recent
review
diseas
induc
prrsv
mani
clinic
manifest
two
preval
sever
reproduct
failur
sow
gilt
character
lateterm
abort
increas
number
stillborn
mummifi
weakborn
pig
respiratori
problem
pig
age
associ
nonspecif
lymphomononuclear
interstiti
pneumon
app
caus
agent
porcin
pleuropneumonia
sever
highli
contagi
respiratori
diseas
respons
major
econom
loss
swine
industri
worldwid
diseas
transmit
aerosol
direct
contact
infect
pig
may
result
rapid
death
sever
patholog
character
hemorrhag
fibrin
necrot
lung
lesion
exposur
organ
may
lead
chronic
infect
anim
fail
thrive
altern
surviv
asymptomat
carrier
transmit
diseas
healthi
herd
mani
virul
factor
microorgan
well
character
date
fifteen
serotyp
app
base
capsular
antigen
describ
preval
specif
serotyp
vari
geograph
region
recent
advanc
pathogen
detect
method
allow
better
understand
interact
pathogen
improv
character
mechan
diseas
potenti
demonstr
import
polymicrobi
diseas
present
studi
vitro
interact
prrsv
app
prrsv
permiss
cell
model
investig
thu
cell
sjpl
cell
line
pulmonari
alveolar
macrophag
pam
use
studi
sinc
shown
previous
permiss
prrsv
infect
replic
result
indic
app
possess
strong
antivir
activ
prrsv
vitro
bacteri
adher
appwt
prrsvinfect
noninfect
sjpl
cell
compar
figur
prior
infect
cell
type
prrsv
significantli
affect
adhes
neither
appwt
strain
auger
et
al
previous
publish
sjpl
cell
death
induc
app
occur
necrosi
apoptosi
consequ
base
previou
report
cytotox
experi
perform
order
verifi
prrsv
infect
increas
cytotox
app
moreov
assay
done
confirm
inactiv
toxin
apxi
apxii
mutant
reduc
cell
death
seen
appwt
strain
thu
ldh
cytotox
assay
detect
cell
death
perform
cell
infect
prrsv
hour
coinfect
appwt
strain
shown
figur
cytotox
activ
appwt
higher
cell
line
hour
incub
around
sjpl
cell
figur
around
cell
figur
compar
one
mutant
hour
incub
less
sjpl
cell
figur
around
cell
figur
expect
mutant
markedli
less
cytotox
parent
strain
appwt
thu
mutant
allow
much
longer
incub
period
cell
facilit
vitro
observ
furthermor
coinfect
prrsv
increas
sjpl
cell
death
compar
app
singl
infect
figur
respect
show
addit
cytotox
effect
prrsv
markedli
reduc
cytotox
use
subsequ
experi
sjpl
cell
coinfect
prrsv
show
absenc
prrsv
n
viral
protein
detect
ifa
compar
control
sjpl
cell
infect
prrsv
alon
figur
suggest
inhibit
prrsv
infect
andor
replic
figur
cell
line
use
compar
result
obtain
sjpl
cell
line
sinc
cell
common
cell
use
vitro
prrsv
studi
interestingli
result
differ
two
cell
line
prrsv
infect
cell
small
reduct
cell
express
prrsv
n
protein
observ
follow
coinfect
figur
thu
sjpl
cell
qualit
respons
app
antivir
affect
cell
moreov
sinc
sjpl
cell
recent
shown
monkey
origin
swine
first
describ
evalu
antivir
activ
app
test
porcin
relev
cell
model
pam
cell
coinfect
prrsv
pam
cell
also
present
total
absenc
prrsv
n
protein
detect
figur
sjpl
cell
figur
suggest
also
inhibit
prrsv
prrsv
vivo
porcin
target
cell
porcin
alveolar
macrophag
incub
uvinactiv
bacteria
prrsv
infect
allow
detect
n
protein
prrsv
ifa
cell
type
figur
show
uvinactiv
bacteria
abl
block
prrsv
infect
interestingli
bacteriafre
cultur
supernat
also
effect
block
prrsv
infect
sjpl
pam
cell
figur
respect
weak
inhibit
observ
cell
figur
ph
vari
test
condit
stabl
around
activ
metabolit
present
cultur
supernat
seem
app
lp
figur
peptidoglycan
fragment
assay
ligand
figur
respect
dilut
supernat
show
dosedepend
effect
prrsv
detect
ifa
dilut
result
twice
much
prrsv
n
protein
observ
ifa
data
shown
loss
antivir
activ
supernat
observ
dilut
prrsv
titer
measur
confirm
ifa
observ
quantifi
inhibitori
effect
prrsv
infect
sjpl
pam
cell
infect
treat
describ
previous
sjpl
cell
hour
post
prrsv
infect
viral
titer
obtain
figur
cell
figur
pam
cell
figur
coinfect
treatment
cultur
supernat
block
complet
prrsv
replic
p
sjpl
cell
figur
cell
antivir
effect
prrsv
replic
markedli
less
effici
specif
cell
prrsv
titer
correspond
fold
decreas
compar
prrsv
nontreat
infect
cell
correspond
fold
decreas
compar
prrsv
nontreat
infect
cell
p
cellfre
cultur
supernat
p
treat
cell
respect
figur
pam
cell
result
obtain
prrsv
titrat
show
live
complet
block
prrsv
replic
p
cultur
supernat
significantli
inhibit
prrsv
infect
pam
reduc
amount
infecti
virion
p
compar
prrsv
infect
correspond
fold
decreas
figur
stimul
cell
app
purifi
lp
coinfect
uv
inactiv
bacteria
effect
prrsv
titer
cell
type
figur
result
confirm
ifa
data
obtain
previous
addit
import
note
inhibit
pam
total
live
observ
previous
sjpl
cell
prrsv
inoculum
treat
cell
cultur
supernat
thu
result
indic
antivir
effect
prrsv
observ
sjpl
cell
also
porcin
alveolar
macrophag
fraction
cell
cultur
supernat
indic
ihnibitori
effect
prrsv
infect
mediat
small
app
metabolit
weight
kda
figur
result
obtain
small
fraction
test
figur
data
shown
kda
figur
addit
treatment
min
low
molecular
weight
app
metabolit
inactiv
ihnibitori
effect
prrsv
infect
andor
replic
sjpl
cell
show
app
antivir
metabolit
heatresist
data
shown
sinc
cell
cultur
supernat
inhibit
prrsv
replic
virus
test
order
verifi
inhibit
viru
specif
gener
antivir
effect
first
sjpl
cell
permiss
test
regard
differ
dna
genom
virus
cpv
well
rna
genom
virus
influenza
influenza
influenza
influenza
virus
abl
infect
replic
sjpl
cell
tabl
thu
treatment
cultur
supernat
perform
infect
virus
sjpl
cell
verifi
spectrum
antivir
activ
overal
virus
test
abl
replic
sjpl
cell
exclud
prrsv
inhibit
cell
cultur
supernat
inhibit
virus
influenza
howev
import
note
inhibit
prrsv
replic
observ
follow
treatment
supernat
significantli
higher
compar
inhibit
observ
influenza
tabl
result
import
indic
sjpl
cell
still
abl
allow
replic
sever
virus
presenc
cell
cultur
supernat
indic
sjpl
cell
still
metabol
activ
fit
virus
replic
sinc
level
mrna
express
type
type
ii
interferon
known
implic
cellular
antivir
effect
prrsv
mrna
level
cytokin
measur
qrtpcr
figur
modul
observ
test
condit
includ
poli
c
control
observ
also
previous
made
provost
et
al
prrsv
infect
sjpl
cell
significantli
increas
level
compar
mock
infect
cell
previous
describ
provost
et
al
treatment
supernant
alon
induc
signific
increas
mrna
compar
mock
infect
cell
cotreat
cell
show
signific
increas
compar
mock
infect
cell
prrsv
infect
sjpl
cell
modul
mrna
level
howev
treatment
supernant
alon
cotreat
significantli
increas
mrna
compar
mock
infect
sjpl
cell
mani
studi
previous
shown
respiratori
viral
infect
increas
bacteri
adher
cell
exampl
influenza
infect
increas
adher
streptococcu
pyogen
mdck
cell
rhinoviru
infect
increas
adher
streptococcu
pneumonia
cultur
human
airway
epitheli
cell
respiratori
syncyti
viru
rsv
human
parainfluenza
viru
influenza
viru
increas
adher
haemophilu
influenza
pneumonia
respiratori
epitheli
cell
howev
present
studi
modul
app
adher
observ
cell
infect
prrsv
appwt
induc
expect
high
percentag
cytotox
sjpl
cell
figur
deriv
express
nonactiv
toxin
apxi
apxii
show
much
lower
cytotox
sjpl
cell
furthermor
previous
describ
provost
et
al
prrsv
infect
sjpl
cell
induc
signific
increas
cell
death
howev
coinfect
prrsv
result
signific
increas
cell
death
compar
prrsv
infect
alon
support
less
toxic
eukaryot
cell
cytotox
mainli
caus
prrsv
coinfect
cell
interestingli
less
toxic
app
mutant
enabl
longer
exposur
vitro
experi
allow
us
observ
app
antivir
effect
prrsv
antivir
effect
first
observ
sjpl
cell
coinfect
prrsv
figur
subsequ
result
show
antivir
activ
also
present
bacteri
supernat
due
app
purifi
lp
nod
ligand
probabl
low
molecular
weight
metabolit
kda
inhibit
prrsv
replic
gener
contact
bacteri
eukaryot
host
cell
sinc
also
observ
app
cell
cultur
supernat
thu
without
presenc
app
bacteri
cell
furthermor
antivir
effect
observ
sjpl
cell
also
prrsv
natur
host
target
cell
ie
pam
suggest
antivir
action
effici
differ
cell
speci
type
viral
inhibit
pam
cell
complet
presenc
bacteria
partial
treat
cell
cultur
supernat
combin
treatment
test
data
obtain
gave
inform
mechan
antivir
activ
supernat
overal
suggest
supernat
antivir
activ
interf
prrsv
attach
entri
experi
current
progress
investig
mechan
supernat
inhibit
prrsv
replic
despit
fact
sjpl
monkey
origin
phenotyp
distinct
demonstr
group
provost
et
al
previou
report
demonstr
sjpl
cell
divis
rate
develop
cytopath
effect
cpe
induc
prrsv
sjpl
cell
delay
compar
cell
furthermor
cytokin
profil
prrsv
infect
differ
two
cell
line
result
suggest
prrsv
infect
could
differ
thu
differ
prrsv
infect
cell
line
could
explain
differ
observ
supernat
antivir
activ
type
ifn
produc
mani
cell
type
part
innat
immun
respons
moreov
well
known
literatur
type
ifn
often
part
cellular
respons
viral
infect
includ
prrsv
infect
result
studi
show
modul
mrna
level
mrna
level
increas
prrsv
supernat
alon
signific
increas
observ
prrsv
supernat
condit
compar
mock
infect
cell
thu
impair
express
follow
cotreat
might
due
prrsv
replic
might
block
ifn
product
induc
supernat
addit
result
demonstr
sinc
prrsv
inhibit
type
ifn
induct
signal
antivir
activ
induc
supernat
may
reli
abil
induc
howev
mean
part
antivir
activ
supernat
sinc
virus
still
sensit
type
ifn
type
ii
mainli
produc
activ
cell
natur
killer
cell
mostli
respons
adapt
respons
part
cellmedi
immun
furthermor
implic
antivir
respons
prrsv
also
demonstr
nonetheless
mrna
level
sjpl
cell
significantli
increas
supernat
alon
prrsv
supernat
condit
observ
might
give
clue
cellular
respons
supernat
induc
antivir
effect
ie
via
increas
mrna
level
cell
howev
import
mention
known
sjpl
cell
possess
receptor
necessari
mediat
signal
investig
need
confirm
hypothesi
prrsv
lead
persist
infect
current
prrsv
vaccin
yet
optim
sinc
lack
abil
induc
strong
immun
respons
sinc
provid
complet
immun
homolog
prrsv
infect
review
see
moreov
prrsv
vaccin
live
attenu
viru
thu
present
safeti
issu
vaccin
pig
shown
produc
shed
virul
prrsv
particl
thu
import
investig
new
possibl
way
control
prrsv
infect
regard
antivir
molecul
metabolit
might
good
altern
current
use
vaccin
recent
publish
studi
show
compound
inhibit
prrsv
glycosid
terpenoid
coumarin
isoflavon
peptolid
alkaloid
flavon
macrolid
nacetylpenicillamin
cyclosporin
sodium
tanshinon
iia
sulfon
flavaspid
acid
ab
ribavirin
morpholino
oligom
compound
deriv
plant
polysaccharid
isol
achyranth
bidentata
mushroom
extract
cryptoporu
volvatu
howev
commerci
avail
antivir
drug
prrsv
market
conclus
best
knowledg
first
descript
app
antivir
activ
studi
might
lead
develop
new
treatment
prrsv
deriv
app
cell
cultur
supernat
howev
investig
need
identifi
andor
purifi
target
metabolit
secret
app
gener
possibl
new
antivir
molecul
prrsv
moreov
sinc
demonstr
antivir
effect
metabolit
secret
app
specif
prrsv
also
effect
rna
virus
antivir
activ
might
well
lead
new
antivir
treatment
exampl
molecul
ribavirin
current
use
human
respiratori
syncyti
viru
rsv
hepat
c
infect
initi
demonstr
broad
antivir
activ
anim
virus
studi
might
therefor
allow
develop
new
antivir
molecul
prrsv
also
virus
influenza
cell
product
order
invitrogen
corpor
gibcobrl
burlington
ca
unless
specifi
cell
subclon
african
green
monkey
kidney
cell
grown
minimum
essenti
medium
mem
supplement
foetal
bovin
serum
fb
wisent
inc
stbruno
qc
canada
mm
hepe
mm
lglutamin
uml
penicillin
streptomycin
gl
antibioticantimitot
solut
sjpl
cell
line
st
jude
porcin
lung
epitheli
cell
provid
dr
rg
webster
st
jude
children
hospit
memphi
tn
usa
later
demonstr
monkey
origin
cell
line
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fb
wisent
inc
mm
sodium
pyruv
mm
lglutamin
mem
nonessenti
amino
acid
uml
penicillin
streptomycin
gl
antibioticantimitot
solut
mgl
gentamicin
porcin
alveolar
macrophag
pam
harvest
lung
week
old
pig
describ
previous
pig
sacrif
follow
ethic
protocol
approv
institut
ethic
committe
de
l
utilis
de
animaux
follow
guidelin
canadian
council
anim
care
briefli
instil
lung
pb
contain
unitsml
penicillin
streptomycin
mgl
gentamicin
realiz
phosphat
buffer
salin
solut
pb
collect
pam
remov
follow
low
speed
centrifug
cell
wash
dmem
medium
complement
mm
lglutamin
mm
hepe
nonessenti
amino
acid
gl
amphotericin
b
wisent
inc
unitsml
penicillin
streptomycin
mgl
gentamicin
cell
collect
follow
low
speed
centrifug
resuspend
freez
medium
wash
medium
plu
foetal
bovin
serum
dmso
sigmaaldrich
stloui
mo
usa
slowli
frozen
store
liquid
nitrogen
util
pam
cell
cultur
hour
complet
dmem
prior
assay
cell
cultur
infect
atmospher
app
strain
use
studi
serotyp
refer
wild
type
strain
appwt
mutant
strain
produc
nonact
apxi
apxii
toxin
kindli
provid
ruud
pam
seger
msd
anim
health
boxmeer
netherland
app
strain
cultur
brain
heart
infus
bhi
broth
andor
agar
gibco
supplement
nicotinamid
adenin
dinucleotid
nad
prrsv
strain
use
studi
canadian
genotyp
ii
refer
strain
iafklop
adher
assay
epitheli
cellswel
seed
welltissu
cultur
plate
sarstedt
numbrecht
germani
incub
overnight
cell
infect
prrsv
multipl
infect
moi
viru
particl
bacteri
cell
per
cell
appwt
overnight
cultur
grown
nm
resuspend
complet
cell
cultur
medium
concentr
cfuml
one
ml
either
suspens
ad
well
moi
hour
prrsv
infect
plate
incub
hour
nonadher
bacteria
remov
wash
four
time
dulbecco
phosphatebuff
salin
dpb
gibco
cell
adher
bacteria
releas
well
ad
trypsinedta
gibco
resuspend
dpb
buffer
serial
dilut
perform
pour
agar
plate
determin
number
bacteria
adher
epitheli
cell
bacteria
coloni
count
coloni
form
unit
per
well
cfuwel
describ
auger
et
al
cytotox
detect
assay
epitheli
cellswel
seed
welltissu
cultur
plate
sarstedt
incub
cell
infect
prrsv
moi
appwt
overnight
cultur
grown
nm
resuspend
complet
cell
cultur
medium
concentr
cfuml
one
ml
either
suspens
ad
well
moi
hour
prrsv
infect
plate
incub
hour
appwt
hour
cellular
cytotox
determin
use
lactat
dehydrogenas
ldh
measur
cytotox
nonradioact
cytotox
assay
promega
madison
wi
describ
manufactur
noninfect
cell
use
neg
control
total
cell
lysat
use
cytotox
posit
control
sinc
ldh
releas
cell
mechan
lyse
optic
densiti
measur
nm
power
wave
biotek
instrument
inc
winooski
vt
micropl
reader
use
calcul
percentag
cytotox
presenc
prrsv
antigen
infect
cell
determin
immunofluoresc
assay
ifa
cell
infect
treat
describ
follow
treatment
andor
infect
cell
fix
paraformaldehyd
pfa
solut
prepar
previous
describ
mockinfect
nontreat
cell
use
neg
control
incub
period
minut
room
temperatur
pfa
solut
remov
cell
wash
three
time
phosphat
buffer
solut
pb
cell
incub
minut
room
temperatur
pb
solut
contain
triton
cell
membran
permeabil
remov
triton
solut
cell
wash
three
time
pbstween
solut
pb
contain
tween
thereaft
cell
incub
minut
pb
contain
tween
foetal
bovin
serum
albumin
rabbit
monospecif
antisera
antin
prrsv
protein
dilut
block
solut
ad
cell
incub
minut
cell
wash
incub
minut
block
solut
contain
dilut
antirabbit
specif
antiserum
fitc
conjug
sigma
final
cell
visual
use
dmi
revers
fluoresc
microscop
imag
cell
taken
dfc
digit
camera
imag
analyz
use
leica
applic
suit
softwar
version
leica
microsystem
inc
richmond
hill
canada
cell
infect
moi
prrsv
incub
dmem
without
serum
addit
hour
nonattach
viru
remov
medium
soft
wash
step
use
pb
thereaft
fresh
medium
ad
overnight
cultur
grown
nm
resuspend
moi
complet
cell
cultur
medium
concentr
cfuml
obtain
uv
inactiv
resuspend
moi
inactiv
hour
uv
light
nm
rock
petri
dish
inactiv
confirm
plate
bhinad
obtain
supernat
resuspend
moi
centrifug
g
minut
harvest
supernat
pass
filter
remov
residu
bacteria
bacteri
cultur
supernat
fraction
ultrafiltr
membran
cutoff
amicon
millipor
billerica
kda
macrosep
pall
life
scienc
port
washington
ny
obtain
cell
cultur
supernat
fraction
supernat
also
dilut
one
ml
suspens
ad
well
hour
prrsv
infect
plate
incub
hour
ph
measur
perform
directli
well
treat
sjpl
cell
use
accumet
basic
ph
meter
fisher
scientif
ottawa
presenc
prrsv
n
antigen
determin
ifa
infecti
dose
viru
determin
serial
dilut
calcul
method
briefli
sampl
infect
prrsv
subject
three
cycl
freezethaw
cellular
suspens
clarifi
low
speed
centrifug
g
minut
supernat
serial
dilut
use
infect
cell
tissu
cultur
plate
plate
incub
hour
viru
titer
express
tissu
cultur
infecti
dose
per
ml
presenc
prrsv
also
evalu
qrtpcr
use
commerci
kit
tetracor
inc
rockvil
md
usa
previous
describ
cell
infect
prrsv
moi
dmem
without
serum
addit
incub
hour
infect
cell
wash
fresh
medium
ad
cell
treat
lp
purifi
appwt
ngml
ligand
invivogen
san
diego
ca
ngml
ligand
invivogen
hour
presenc
prrsv
n
protein
determin
ifa
viru
titer
determin
describ
dna
genom
virus
use
experi
bovin
herp
viru
type
strain
porcin
circoviru
strain
bovin
adenoviru
bovin
herp
viru
type
canin
parvoviru
cpv
equin
herp
viru
type
rna
genom
virus
use
experi
bovin
viral
diarrhea
viru
type
strain
nadl
atcc
swine
influenza
strain
swine
influenza
strain
cell
infect
viru
differ
dilut
hour
dmem
describ
prrsv
treat
cultur
supernat
hour
describ
infecti
dose
viru
calcul
describ
prrsv
use
sjpl
cell
sjpl
cell
pam
treat
infect
describ
transfect
acid
potassium
salt
poli
c
sigmaaldrich
inc
stloui
usa
posit
control
innat
immun
induct
use
polyethylenimin
pei
sigma
hour
treat
lipopolysaccharid
lp
e
coli
sigma
hour
induc
total
cellular
rna
extract
cell
use
trizol
reagent
invitrogen
burlington
canada
accord
manufactur
protocol
quantif
rna
perform
nanodrop
nanodrop
technolog
inc
wilmington
delawar
usa
total
rna
reversetranscrib
use
quantitect
revers
transcript
kit
qiagen
mississauga
canada
cdna
amplifi
use
ssofast
evagreen
supermix
kit
biorad
hercul
ca
usa
pcr
amplif
program
cdna
consist
enzym
activ
step
min
follow
cycl
denatur
step
sec
annealingextens
step
sec
primer
use
amplif
differ
target
cdna
previous
describ
provost
et
al
primer
test
achiev
amplif
effici
primer
sequenc
design
ncbi
genbank
mrna
sequenc
use
webbas
softwar
primerquest
integr
dna
technolog
biorad
sequenc
detector
apparatu
use
cdna
amplif
quantif
differ
differ
group
calcul
use
method
microglobulin
use
normal
gene
compens
potenti
differ
cdna
amount
noninfect
pam
sjpl
cell
use
calibr
refer
analysi
twoway
anova
model
follow
bonferroni
posthoc
test
graphpad
prism
version
softwar
use
determin
statist
signific
differ
exist
infect
perform
adher
cytotox
assay
oneway
anova
model
follow
tukey
multipl
comparison
test
graphpad
prism
use
determin
statist
signific
differ
exist
prrsv
titer
obtain
sjpl
pam
cell
unpair
test
use
qrtpcr
statist
analysi
differ
consid
statist
signific
p
